Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran - Wikidata - wikimedia - TriplyDB

Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran

Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran

http://www.wikidata.org/entity/Q35851167

about

Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis Epidemiology of hepatitis C virus in Iran HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006 Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.Controversies in and challenges to our understanding of hepatitis C.Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors among Prisoners in Southern Khorasan Province, Iran.Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006).Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran.Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran.Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran Risk of hepatitis B and C infections in Tehranian wrestlers.Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia.Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey.Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran.Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran.Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment.An overview about hepatitis C: a devastating virus.Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran.Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.HIV and Viral Hepatitis Among Imprisoned Key Populations.A Mathematical Model for Assessing the Impact of Intravenous Drug Misuse on the Dynamics of HIV and HCV within Correctional Institutions

P2860

Q26745482-1C31B491-A526-43AA-934A-4635BDD9B420 Q26781996-2B5F33C4-1565-421D-8521-AF2CD7339059 Q27013667-3A0B2ABE-131C-4409-AD70-5B5677348239 Q27488500-355DD505-77A1-4CEB-A1DA-B9DC6A8AE2F1 Q28553974-E4F301A7-E29B-4B86-A14A-13C97CEC7520 Q33323077-73632617-7787-449C-A4B1-6C24D11C1DC2 Q34255407-8A5DC3E6-8C20-434F-8347-638D751A857C Q34604806-E47B78F9-7638-479F-9E25-ABB2FBA1F0C6 Q35093629-5B8E5999-9C88-4C4F-B589-56EECBB43D0E Q35507204-8248CC4C-991E-4147-A154-27EA6F78A658 Q35670065-6282BB06-9C2F-49C9-81F2-93A486E4C171 Q35724557-4CB1CA2E-5065-4847-A67C-AF9A363C2197 Q35819898-E996B510-4D09-4318-B99F-844C5F9CE07F Q35970414-CB82E57D-6D99-48BF-AD75-EDAE80F963C5 Q36101843-1668F082-C728-4421-B7F0-645D5B43781F Q36101848-FDBD1165-12E8-470F-B7DC-CCC01575932B Q36101899-A5553407-D779-4422-AADE-07908AF7BC27 Q36101954-F70B95A7-41D9-4C30-8C0E-5CAA82C838A5 Q36164428-43D3958A-C339-450F-A75C-F5BA92B7C11B Q36192394-EDCC6ECA-9886-45FD-A754-08BD02DC59ED Q36329361-60E95488-7C89-407B-BD74-C6FBF308F31D Q36454765-36AE115B-8236-4B7B-BED9-42674BA7C1B7 Q36828863-A8CB433F-DD98-4CC3-AE7D-62A6E5DCC679 Q36879898-1750021C-5575-4E14-816E-BA9D17D76787 Q37306146-9DD0F5D7-F680-4F6F-A8A1-14EFB9350339 Q37387183-96600FE6-F297-421D-BF3F-9EA2E4822759 Q37423218-DE1AEED3-D845-4BA0-9E1F-5F771F0AC9D6 Q37719516-EB4AFAF6-21CB-4E43-8B0F-19DDDD5297A5 Q37975114-72F7DEA4-52C4-4401-B18D-18CE335FF202 Q39928379-9C2BB54E-3903-4D92-9187-5C044BB8877D Q39974152-60C11930-17EF-4F51-AC25-2111E68E8A95 Q42981211-631B8690-2232-43E7-8467-B730FFE8E694 Q47556282-CC7BB23D-001F-4F7A-9352-B0FCFC77A61E Q53403318-21600AEB-9E9C-4690-A2C5-AC58053942F6 Q58905366-CF2499DF-C1E9-4B40-AFC9-EE85B1FFF614

P2860

Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran

http://www.wikidata.org/entity/Q35851167

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@ast

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@en

type

label

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@ast

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@en

prefLabel

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@ast

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@en

P1433

Q35851167-756550F9-956D-47E8-B305-ADF510E01620

P1476

Q35851167-5B5F6E22-ABF8-4CB7-ABC7-3A8B09C19454

P2093

Q35851167-2BD17BE9-7FCA-4840-9728-1B1EA3067E46

Q35851167-61E53A0D-55E5-457D-A876-936643CFAFA5

Q35851167-689C009D-90E6-4E7B-B814-CCB595D9C679

Q35851167-8B84BACC-1861-4CC5-BFAA-D4655D21BF46

P2860

Q35851167-0488ABD6-7BD6-4DCC-AA41-5C475B2AE73C

Q35851167-10AD7E64-62BB-4CE6-82D2-3A6B3818D13A

Q35851167-1CB68C19-6128-46FB-BE54-E7333A5A54BC

Q35851167-27C8F70E-D360-489D-8E14-21279EF44B82

Q35851167-2F4E29D5-2760-48BF-B5D2-5BD162EBA447

Q35851167-3326568D-C11F-40C4-B829-63DAAE2007D1

Q35851167-347920C4-BAC0-42AD-A622-06FC7EA97D23

Q35851167-360E4D3A-8EC7-49F2-B653-E8AA17054C8A

Q35851167-45A68B10-B3A6-4A47-B81D-5D4AA39F2D0E

Q35851167-5282F09D-4160-4227-A798-533B7328FBFB

P304

Q35851167-354F7579-FAAA-47F8-B986-5473CA24182A

P31

Q35851167-35EF37CC-BC94-4123-BD41-8134BFF593D9

P356

Q35851167-66671E70-B7EB-4C4C-ACBD-1DF9FBBE9334

P407

Q35851167-BFA97109-1BD6-4188-A94A-5F9736942026

P433

Q35851167-789879E6-5D42-4A54-B6D9-D24B04DE43D8

P478

Q35851167-2DF6C89A-5E21-4D6E-9F45-1741DDA7BE41

P577

Q35851167-CC5A3884-1C03-43EF-89E9-09373EF9896F

P5875

Q35851167-541BEC29-AA04-4E47-941B-D3DE24E3EA88

P698

Q35851167-02CDC1B9-A2BD-40FC-8C22-A86376742A19

P921

Q35851167-681A9547-6A17-4331-9D45-29CD06F6A7AB

P932

Q35851167-589B4928-7A25-4A39-840E-6A3B5E967572

P356

WJG.V11.I26.4085

P1433

World Journal of Gastroenterology

P1476

Prevalence of hepatitis C viru ...... ser prisoners in Hamedan--Iran

@en

P2093

Amir Houshang Mohammad Alizadeh

http://www.w3.org/2001/XMLSchema#string

Khalil Jafari

http://www.w3.org/2001/XMLSchema#string

Nastaran Yazdi

http://www.w3.org/2001/XMLSchema#string

Seyed Moayed Alavian

http://www.w3.org/2001/XMLSchema#string

P2860

The potential role of custody facilities in controlling sexually transmitted diseases

Epidemiology of hepatitis C

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

Hepatitis C virus infection in the United States.

HIV prevention in prisons and jails: obstacles and opportunities.

Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women

Study of infection with HIV and related risk factors in young offenders' institution.

Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.

Prevalence of HIV and injecting drug use in men entering Liverpool prison

Drug injection and HIV prevalence in inmates of Glenochil prison.

P304

4085-4089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I26.4085

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286434485

http://www.w3.org/2001/XMLSchema#string

P698

15996035

http://www.w3.org/2001/XMLSchema#string

P921

P932

4502106

http://www.w3.org/2001/XMLSchema#string